JPS5946202A - Antifungal agent - Google Patents

Antifungal agent

Info

Publication number
JPS5946202A
JPS5946202A JP15758282A JP15758282A JPS5946202A JP S5946202 A JPS5946202 A JP S5946202A JP 15758282 A JP15758282 A JP 15758282A JP 15758282 A JP15758282 A JP 15758282A JP S5946202 A JPS5946202 A JP S5946202A
Authority
JP
Japan
Prior art keywords
compound
formula
reaction
reacted
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15758282A
Other languages
Japanese (ja)
Other versions
JPH0330565B2 (en
Inventor
Yukihiko Isoe
磯江 幸彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP15758282A priority Critical patent/JPS5946202A/en
Publication of JPS5946202A publication Critical patent/JPS5946202A/en
Publication of JPH0330565B2 publication Critical patent/JPH0330565B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:An antifungal agent useful as a drug, for agriculture and horticulture, sterilization for external use, etc., having improved antifungal action, comprising (E)-8beta, 17-epoxylabd-12-ene-15,16-dial as an active ingredient. CONSTITUTION:An antifungal agent comprising (E)-8beta, 17-epoxylabd-12-ene-15, 16-dial as an active ingredient shown by the formula I . The compound is known to occur in the seed of afromomum daniellii belonging to the family Zingiber, and obtained by the following process. A compound shown by the formula II is reacted with KCN, etc. to give a compound shown by the formula III, which is reduced, and reacted with ethylene glycol to give a compound shown by the formula IV. This compound is reacted with diisobutylaluminum hydride, treated in the presence of an acid catalyst, reacted further with a compound shown by the formula V to give a compound shown by the formula VI. This compound is reacted with ethylene glycol, made into an alcohol, subjected to lower alkanoyl reaction, epoxidized, hydrolyzed, and finally treated with an oxidizing agent, to give the compound.

Description

【発明の詳細な説明】 本発明は抗力ご剤に関J′る。史に詳しくは本発明は、
式 で示される(E)−8β.17−エボ4;シラブ1:ー
12ーエンー15.16−ジアールを有タJ成分どして
含有J゛るこどを特徴とづ゛る族カビ剤に係る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to drag agents. For details on the history, the present invention is
(E)-8β. 17-evo 4; Silab 1: -12-en-15. This relates to a fungicide of the group J, which is characterized by containing -15,16-dial as the J component.

上記式(1)の゛{l二a物は、ショウガ利のアフロモ
ヌム ダニエリ(ΔrrObloblllil  da
niellli )の柚子に存在することが知られてい
る[8.F。
The compound in the above formula (1) is Afromonum danieri (ΔrrOblobllil da
nielli) is known to exist in yuzu [8. F.

Kln+l+u.  T.  N.  Njl+ni.
  [3.  l−、’SontlenOaIl+。
Kln+l+u. T. N. Njl+ni.
[3. l-,'SontlenOaIl+.

LJ. A. Aklnnlyi 、 J. D. G
OIlnQllV 、 J。
L.J. A. Aklnnlyi, J. D. G
OIlnQllV, J.

CI+en+ 、 Soc. 、 Perkin  T
rans, 1 。
CI+en+, Soc. , Perkin T.
rans, 1.

1303(1070’>春1(t ]。本弁明者らは、
上記式(1)の化合物の生理活性について種々の?jl
究を川ねた結果、該化合1カが優れた抗力ピ作用を有し
ていることを見出(ノた。本発明(ま斯かる知見に其づ
き完成されたbのである。
1303 (1070'>Spring 1 (t). The present defenders,
What are the various physiological activities of the compound of formula (1) above? jl
As a result of extensive research, it was discovered that this compound had an excellent anti-drag effect.The present invention was completed based on this knowledge.

上記式(1)の化合物は、例えば以下に示ず方)ムに従
い1造される。
The compound of formula (1) above can be prepared, for example, according to the method shown below.

(2)          (3) (4)          (5) (6)         (7) (8)             (9)(In)  
          (11)(12)       
      (13)[R’及びR2は同−又は異なっ
て、メチル、エチル、ブ日ピル、イソプロピル、ブチル
、tert−ブチル基等の低級アルキル基を示ず。
(2) (3) (4) (5) (6) (7) (8) (9) (In)
(11) (12)
(13) [R' and R2 are the same or different and do not represent a lower alkyl group such as methyl, ethyl, butyl, isopropyl, butyl, or tert-butyl group.

R3はアセチル、プロピオニル、ブチリル、イソブチリ
ルM’Jの低級アルカノイル 不発明において出発原料として用いられる式(2)の化
合物は公知の化合物である。式(2)の化合物から式(
3)の化合物を1(Iる反応は、)l当な)1j媒中で
式(2)の化合物に式MCN  、     (14) c式中N・1はす1〜リウム、カリウム等のアルカリ金
属原子を承り。]を作用させることにJ:り行なわれる
。)a碌どしては不活性溶媒である限り公知のものを広
く使用でき、例えば水、ジメチルスルホキシド、ジメチ
ルホルムアミド、ヘキリメチルリン酸トリアミド、ア1
?1〜ニトリル、アtel・ン等の極性)d線を挙げる
ことノlりできる。式(2)の化合物ど式( 1 lI
 >の化合物どの使用^り含とUては、特にIn定がな
く広い範囲内から;a官)11択できるが、通常前者に
対して後者を少くとb等モル稈1宜、好ましく(ま等モ
ル〜2 4r’rモル稈1立使用°ツるのがJ二い。
R3 is acetyl, propionyl, butyryl, lower alkanoyl of isobutyryl M'J The compound of formula (2) used as a starting material in the invention is a known compound. From the compound of formula (2), formula (
The reaction in which the compound of formula (3) is converted to the compound of formula (2) in a suitable medium is MCN, (14) where N・1 is 1 to an alkali such as lithium or potassium. Accepts metal atoms. ] is performed. ) A wide range of known solvents can be used as long as they are inert solvents, such as water, dimethyl sulfoxide, dimethyl formamide, hexylymethyl phosphoric triamide, and
? 1 to nitrile, atel, etc.) d-line can be mentioned. The compound of formula (2) has the formula ( 1 lI
The use of the compounds listed above is not particularly determined and can be selected from a wide range; however, it is usually preferable to use a smaller amount of the latter with respect to the former. Equimolar to 24r'r mol culm used per stand is J2.

該反応の反応温度としては′411こ制限されないが、
通)K O〜8 0 ’C 19度、好Jニジ<は至温
稈1σにて反応’h\好適に進行し、一般(こ2〜E’
S時間程痘で反応は完結する。尚該反応を実施づるに1
′みミしては、反応系内に塩化アンモン、ruff i
’+!アンモン等の強り々アンモニウム塩を存在ざして
おくの7)(好ましい。斯くして式(3)の11色物が
11ソ4!Iされる。
The reaction temperature of the reaction is not limited to 411, but
KO ~ 8 0 'C 19 degrees, the reaction 'h\ progresses suitably at the lowest temperature culm 1σ, and general (this 2~E'
The reaction is complete in about S hours. In addition, to carry out the reaction 1
If the mixture is mixed, ammonium chloride and ruff i are added to the reaction system.
'+! Preferably, an ammonium salt such as ammonium is present (7) (preferably). In this way, the 11-colored substance of formula (3) is converted to 11 so4!I.

式(3)の化合物から式< lI > o)IL;合物
を)ηる反応1ま、式(3)の化合物を)V元Jること
により行な4)れる。用いられる;υ元触媒としては、
通常の還元触媒を広< 11t!川でき、例えはバラジ
ウlい、1096−パラジウムが!水、ラネーニッケル
、白金piの19元触媒を皐げることができる。還元触
媒の沈用聞としては通常の触媒量でJ:い。また溶媒と
しては不活性な)d媒である限り公知のilJ媒を広く
使用でき、l5IJえばメタノール、エタノール等の低
級アルコール力1、ジエチルエーテル、ジオキ1ナン、
テI・ラヒドロフラン等のエーテル類等を挙げることが
できる。該反応の反応)島洩としては1、rに制限され
ないが、通常O〜50’C程度、好ましくは苗渇桿度に
て反応が好適に進行し、一般に2〜811.¥間程度で
反応は完結Jる。斯くして式(4)の化合物が収+4?
される。
Reaction 1 is carried out by converting a compound of formula (3) into a compound of formula <lI> o) IL; Used; As a υ primary catalyst,
Widespread use of ordinary reduction catalysts < 11t! A river is made of palladium, for example, 1096-palladium! It can heat a 19-way catalyst of water, Raney nickel, and platinum pi. As for the precipitation of the reduction catalyst, the normal amount of catalyst is J. In addition, as long as the d medium is inert (as a solvent), a wide range of known ilJ media can be used.
Ethers such as TeI-lahydrofuran and the like can be mentioned. Reaction of the reaction) Although the temperature is not limited to 1.r, the reaction normally proceeds suitably at a temperature of about 0 to 50'C, preferably at a seedling drought rate, and is generally 2 to 811. The reaction is completed in about ¥200. Thus, the compound of formula (4) yields +4?
be done.

式(4)の化合物から式(5)の化合物を14る反応は
、酸触媒の存在下式(4)の化合物にエチレングリコー
ルを反応させることににり行む4)れる。使用される酸
触媒としては例えばI)−1−ル:[ンスルホン酸、ベ
ン1!ンスルホンM、エタンスル小ン酸等のスルホン酸
類、想化水素ガス、ry?! h!!笠の鉱酸等を塁げ
ることができる。式(4)のfl−A物とエチレングリ
コールとの使用割合と1ノでは、特に限定7ノ(なく広
い範囲内から適宜3i!i択できるが、通7i4前省に
対して後者を少くとも等モル相反、好ましく−は1〜2
倍モル程庶使用するのがよい。また溶媒としては不)古
性な溶媒である限り公知の)8媒を広く使用でき、例え
ばベン1!ン、;−ルエン等の芳香族炭化ホメ< yj
t等を挙げることができる。該反応の反応調度としては
特にalll l!I+!されないツノ(、通常)B媒
ノ沸点f」近、好#ニジ< L、L 80〜120 ’
C程度にて反応が好適に進行し、一般に1〜6詩聞程庭
で反応は完結する。斯くして式(5)の化合物が収+1
される。
The reaction of forming the compound of formula (5) from the compound of formula (4) involves reacting the compound of formula (4) with ethylene glycol in the presence of an acid catalyst. Acid catalysts used include, for example, I)-1-l:[sulfonic acid, Ben 1! Sulfonic acids such as ethanesulfone M, ethanesulfonic acid, hydrogen gas, ry? ! h! ! You can use it to spread mineral acid, etc. Regarding the usage ratio of fl-A substance and ethylene glycol in formula (4), it is possible to select 3i!i as appropriate from a wide range of 7i! Equimolar reciprocity, preferably - is 1 to 2
It is best to use twice the molar amount. Further, as a solvent, a wide range of known solvents can be used as long as they are old-fashioned solvents, such as Ben 1! Aromatic carbonized homeols such as
Examples include t. As a reaction preparation for this reaction, especially all l! I+! The boiling point of medium B (usually) is close to f', good #niji < L, L 80~120'
The reaction proceeds suitably at about C, and is generally completed within 1 to 6 cycles. In this way, the compound of formula (5) was obtained +1
be done.

式(5)の化合物iJr lう式(6)の111合物4
−得る反応は、適当1.K FU媒中式(5)の化合物
にジ、Cソブヂルアルミ二F、“ツムじ1;す1:を反
応ざぼることにJ−り行なわれる。式(5)011ヒ音
物とジイソブチルアルミニウムヒドリドとの使用割合と
しては、特に限定hXなく広い範囲内から適宜選択でき
るん<、通爪前者に対して(侵者を少くとも線モル程度
、好ましく(J停モル〜1.5倍モル程1哀使用−する
のh<よい。)Ir媒としては不活性な)2f碌である
限り公知の)a媒を広く使用でき、1シ1えば11−ヘ
キサジ、シクロ゛ベキサン等の飽和炭化水素類等を埜げ
ることができる。該反応の反応温度としては特に制限さ
れないが、通常−70℃〜V温程度、好ましくは−70
〜−20℃!!i!度にて反応が好適に進行し、一般に
30分〜5助間程度で反応は完結する。斯くして式(6
)の化合物が収(Uされる。
Compound iJr of formula (5) 111 Compound 4 of formula (6)
- The reaction obtained is appropriate 1. The reaction is carried out by reacting the compound of formula (5) with diisobutylaluminum diF, "Zumji1;Su1:" in a KFU medium. The proportion of hX to be used can be appropriately selected from a wide range without any particular limitation. It is possible to use a wide range of well-known a) media as long as they are inactive as Ir media, such as saturated hydrocarbons such as 11-hexadi, cyclobexane, etc. The reaction temperature for this reaction is not particularly limited, but is usually about -70°C to V temperature, preferably -70°C.
~-20℃! ! i! The reaction progresses suitably in about 30 minutes to about 5 hours, and is generally completed in about 30 minutes to 5 minutes. Thus, the formula (6
) is collected (U).

TC(6)の化合物から式(7)の化合物を(ηる反応
は、r1!触媒の存在下適当な)a媒中にて式(6)の
1L合物を処理することにより行なわれる。酸触媒とし
ては例えば酢酸、トリクロルら1酸等の低級11tj 
nh酸、塩酸、1.lIi酸等の鉱酸等をかげることが
できる。斯かる酸触媒の使用量としては、特に制限され
ず広範囲内で適宜選択することができるが、通常式(6
)の化合物に対して過剰l用いるのlJ(よい。)d媒
としては不活性な)8媒である限り公知の)d媒を広く
使用でき、例えば酢酸、プロピオンli!1等の11(
松脂肪酸、ジオキリン、テトラヒドロフラン等のエーテ
ル類等の含水)k1媒等を挙げることができる。MA反
応の反応温皮として(J待に制限されないが、通常室温
〜120℃程1η、好ましくは50〜90℃程度にて反
応が好適に進行し、一般に10分〜2時聞程度で反応は
完結ターる。斯くして式(7)の化合物が収(;すされ
る。
The reaction of converting the compound of formula (7) from the compound of TC(6) (η) is carried out by treating 1L of the compound of formula (6) in a suitable a medium in the presence of a r1! catalyst. Examples of acid catalysts include lower 11tj acids such as acetic acid, trichloro, etc.
nh acid, hydrochloric acid, 1. Mineral acids such as IIi acid can be used. The amount of the acid catalyst to be used is not particularly limited and can be appropriately selected within a wide range.
A wide range of known d-medias can be used, as long as they are inert as d-medias, such as acetic acid, propion, li! 1st place 11 (
Examples include water-containing (water-containing) k1 media such as pine fatty acids, diochirin, ethers such as tetrahydrofuran, and the like. As a reaction skin for MA reaction (although not limited to J waiting time, the reaction normally proceeds suitably at room temperature to 120°C, preferably about 50 to 90°C, and the reaction generally takes about 10 minutes to 2 hours. The compound of formula (7) is thus obtained.

式(7)の化合物から式(8)の化合物を1#る反応は
、適当な溶媒中式(7)の化合物に式[式中R1及びR
2μ前藺にIr1Jじ。Pl+はフェニル基を示ず。]
で表わされる化合物を反応させることにより行7J i
)れる。式(7)の化合物ど式(15)の化合物との使
用割合どしてIt 、特に限定がなく広い範囲内から適
宜選択できるが、通常前者に対して後者を少くとb等モ
ル根石、好ましくは等モル〜2 ifsモル程1宜使川
り°るのlJ(J:い。用いられる)U媒どしては不活
111なンu媒である限り公知の溶媒を広く使用でき、
ISlえはベンゼン、トルエン等の芳V1畝り1化水1
7知等を挙げることができる。′核反応の反応)a度と
しては特にルリ限されないが、通常50〜150℃程度
、好ましくは70〜100’C程度にて反応が好適に進
行し、一般に10〜30時間程度で反応は完結する。斯
くして式(B )の化合物が収得される。
The reaction for preparing the compound of formula (8) from the compound of formula (7) is carried out by adding the compound of formula (7) in an appropriate solvent to the compound of formula [where R1 and R
Ir1J in front of 2μ. Pl+ does not represent a phenyl group. ]
Line 7J i by reacting the compound represented by
) will be. The ratio of the compound of formula (7) to the compound of formula (15) is not particularly limited and can be appropriately selected from a wide range, but usually, if the latter is less than the former, it is preferably equal to b equimolar. is equimolar to 2 ifs moles to 1 Gishigawa Riruru lJ (J: I. Used) As the U medium, a wide range of known solvents can be used as long as they are inert 111 U medium,
ISl is a mixture of benzene, toluene, etc. V1 ridge 1 water 1
7 knowledge etc. can be mentioned. 'Reaction of nuclear reaction) A degree is not particularly limited, but the reaction normally proceeds suitably at about 50 to 150°C, preferably about 70 to 100'C, and the reaction is generally completed in about 10 to 30 hours. do. A compound of formula (B) is thus obtained.

式(8)の化合物から式(9)の化合物を得る反応は、
前記式(4)の化合物から式(5)の化合物を1ける反
応と同ねtの反応条件下にて行へねれる。
The reaction to obtain the compound of formula (9) from the compound of formula (8) is
The reaction is carried out under the same reaction conditions of t as the reaction in which the compound of formula (5) is subtracted by 1 from the compound of formula (4).

式(9)の化合物から式(10)の11】合物を)Uる
反応は、式(9)の化合物を還元J′ることにより行な
われる。用いられる還元触媒どしては、例えば水素化ア
ルミニウムリチウム等を琲げることができる。斯かる還
元触媒の使用ムとしては特に制限されず広範囲内で適宜
選択J”ることができるが、通常式(9)の化合物に対
して少くども等モルロ程度、好ましくは等モル〜21Δ
モルに1程頂とするのがよい。また)8媒としては不活
性なt& Wである限り公知の)a媒を広く使用でき、
例えばジエチルエーテル、テトラヒドロフラン等のエー
テル−′31等を挙げることができる。該反応の反応)
!#αどしては特に制限されないlr(、通1)10°
0〜笛渇t!i!位、好ましくは苗)!稈tftにてf
7応1r<好適に進行し、一般に1〜501間程度で反
応(」完結Jる。IIIi < シて式(10)の化合
物がl+!:! (!7される。
The reaction of converting the compound of formula (10) from the compound of formula (9) is carried out by reducing the compound of formula (9). The reduction catalyst used may be, for example, lithium aluminum hydride. The reduction catalyst to be used is not particularly limited and can be appropriately selected within a wide range, but it is usually at least equimolar to the compound of formula (9), preferably equimolar to 21Δ
It is best to add about 1 molar amount. In addition, as the 8 medium, the well-known a medium can be widely used as long as it is an inactive t & W.
Examples include ether-'31 such as diethyl ether and tetrahydrofuran. reaction)
! #α is not particularly limited lr (, 1) 10°
0~Fuetsut! i! (preferably seedlings)! f at culm tft
The reaction proceeds suitably and is generally completed within a range of about 1 to 501 times.

式(10)の化合物から式(11)の化合物を得るには
、まず式(10)の化合物を(I(級アルカノイル化反
応ざゼ、次いで(Uられる化合物を1112ケタ一ル化
反応ざじればJ:い。11(級アルカノーfル化反応I
J、In基性化合物の存在下式(1o)の化合物に低級
アルカン酸九(ホ物°t” If(級アルカン酸ハロゲ
ン化物を反応ざliることにJ:り行なわれる。式(1
0)の化合物と11(級アルカン1ツ無ホ物乃芋イ1(
級アルカン醸ハロゲン化物どの1山川M合どしては、特
に限定がなく広い舵囲内から遍r+’ i)I択できる
が、通常firs者に対して缶石を少くど+)2倍モル
程度、好ましくは2〜5培モル稈バE便用−りるのlf
i J:い。
In order to obtain the compound of formula (11) from the compound of formula (10), first the compound of formula (10) is subjected to a (I(class) alkanoylation reaction, and then the compound (U) is subjected to a 1112-digit alkanoylation reaction. BJ: I.11 (class alkanolization reaction I
The reaction is carried out by reacting a lower alkanoic acid halide with a compound of formula (1o) in the presence of an In-based compound.
Compound 0) and 11(class alkane 1)
There are no particular restrictions on the level of alkane-brewing halides, and you can choose from within a wide range of r+' i)I, but it is usually about 2 times the molar amount compared to first users, with a small amount of limestone. , preferably for 2 to 5 cultured Mor. culm E stool - Rirunolf
i J: Yes.

用いられる塩■性化合物として1」、1シリえば11−
ジメチルアミノピリジン、ピリジン、トリエチルアミン
等の第三級アミン+(を挙げることljiできる。
The salt compound used is 1'', 1 silicate is 11-
Tertiary amines such as dimethylaminopyridine, pyridine, and triethylamine can be mentioned.

また°)8媒としては不活性な溶媒である限り公知のf
& Wを広く使用でき、例えばピリジン、I・リエチル
アミン等の第三級アミン、ベンゼン、トルエン等の芳香
1■炭化水水類、ジオギ!ナン、テトラヒドロフラン等
のエーテル類等を4′−けることができる。
In addition, as long as the solvent is inert, known f
& W can be widely used, for example, pyridine, tertiary amines such as I-ethylamine, aromas such as benzene, toluene, etc. 1■ Hydrocarbon water, geogly! Ethers such as Nan, tetrahydrofuran, etc. can be used as 4'-groups.

核反応の反応渇1mとしてIII特に制限されないが、
通り也O−・70°C稈痘、好ましくは室)1」稈口〔
にて反応が&7通に進行し、一般に3〜15時間程時間
面応は充11hする。斯くして得られる化合物のl1f
2ケク一ル化反応は前記式(6)の化合物から式(7)
の化合物を得る反応と同様の反応条件下にて行な4つれ
る。
As the reaction temperature of nuclear reaction is 1 m, III is not particularly limited, but
Toriya O-・70°C culm, preferably chamber) 1" culm [
The reaction proceeds over 7 times, and the reaction time is generally about 3 to 15 hours, approximately 11 hours. l1f of the compound thus obtained
In the 2-kekyl synthesis reaction, the compound of formula (6) is converted to formula (7).
Four reactions were carried out under similar reaction conditions to those for obtaining the compound.

式(11)の化合物から式(12)の化合物を()るに
は、まず式(11)の化合物をエポキシ化反応させ、次
いでj(Iられる化合物を(1級アルカノ−(ル化反応
させればよい。エポキシ化反応は、適当’j: :i:
媒中にて式(11)の化合物にトリメチルスルホニウム
−rリド試共を作用ざUることにより行なわれる。トリ
メチルスルホニウム−rす1!81℃薬は1シ1えば1
ヘリメチルスルホニウムア−rオダーCF、水素化すト
リウムl及びジメチルスル小キシ1:からLl!製され
る。斯かる8、(鶏の使用Uどしては、特に制限されず
広範囲内で遍官遣択覆ることができるが、通常式(11
)の化合物に対して少くども等モル石程度、好ましく 
IJ等モル〜21ざモル聞稈痘どするのh(よい。J:
だ+tr媒どしては不活性’l li7 媒である限り
公知の溶媒を広く使用でき、例λばジメチルスル 1ナン、テトラヒドロフラン等のJ−テルブ了1(ンを
挙げることができる。該反応の反応温度としては特に制
限されないが、通’/!130°C〜室温程1ηにて反
応が好)Iに進行し、・−4(目こ30分〜2時間程1
なで反応は完結J゛る。斯くして+4?られる化合物の
11(級アルカノイル化反応は、11rE紀式( 1 
0 )の化合物の111級アルカノ−rル化反応ど同(
コ1の反応条1′1.下にて行なえはJ:い。1υiく
して式( ’+ 2 )の化合物が117(すされる。
In order to obtain a compound of formula (12) from a compound of formula (11), first the compound of formula (11) is subjected to an epoxidation reaction, and then the compound of formula The epoxidation reaction can be carried out using the appropriate 'j: :i:
This is carried out by reacting the compound of formula (11) with trimethylsulfonium-r-lide reagent in a medium. Trimethylsulfonium-r 1! 81℃ drug is 1 shi 1 example 1
Helimethylsulfonium a-rodder CF, thorium hydride and dimethylsulfonyl 1: to Ll! Manufactured. 8. (The use of chickens etc. is not particularly restricted and can be varied within a wide range, but the usual method (11)
) is at least equimolecular, preferably
IJ equivalent mole to 21 mole amount of culm (good.J:
As the medium, a wide variety of known solvents can be used as long as they are inert solvents, such as dimethylsulfonate, tetrahydrofuran, etc. The reaction temperature is not particularly limited, but the reaction preferably proceeds at a temperature of 130°C to room temperature (about 1η).
The stroking reaction is complete. So +4? The 11(class) alkanoylation reaction of the compound is expressed by the 11rE formula (1
0) 111-class alkanolization reaction of the compound (
Co1 reaction column 1'1. Do it below J: No. After 1υi, the compound of formula ('+ 2 ) is sipped.

式(12)の化Δ物から式(13)の化合lI!Jを4
i?る反応は、3U ”:h /.’r. Lhす1(
の存在下式( 1 2 >の化合物を加水分ん7Jるこ
とにJ:り行な1)れる。用いられる触屍どしては、例
えば炭酸すトリウノ1、炭酸Δ(水ブー 1−リウム、
炭酸カリウム等の塩基性化合v/J等/メψけられる。
Compound lI of formula (13) from compound Δ of formula (12)! 4 J
i? The reaction is 3U'':h/.'r.Lhs1(
A compound of formula ( 1 2 >) is hydrolyzed in the presence of 1). The substances used include, for example, carbonic acid 1-1, carbonic acid Δ (water-boulium 1-lium,
Basic compounds such as potassium carbonate v/J, etc./metal are used.

斯かる触媒の使用はとしては通ン:−の触媒Mでよい。The use of such a catalyst may be as follows: -Catalyst M.

溶媒としては不活性な溶媒である限り公知の)g媒を広
く使用でき、例えば水、メタノール、エタノール等の低
級アルコール等を挙げることができる。該反応の反応+
p+ηと1ノでは特に制限されないが、通常至渇〜50
°C1早磨、好ましくは苗)n程度にて反応が好適に進
行し、一般に1〜5時間程度で反応は完tI!iする。
As the solvent, a wide variety of known solvents can be used as long as they are inert solvents, such as water and lower alcohols such as methanol and ethanol. reaction + of the reaction
There is no particular limit for p + η and 1, but it is usually extremely thirsty ~ 50
The reaction progresses suitably at about 1°C (1°C, preferably seedlings), and is generally complete in about 1 to 5 hours. i do

1lli < して式(13)の化合物が収得される。A compound of formula (13) is obtained.

式(13)の11′、凸物から式(1)の化合物を得る
反応は、ジメチルスルホキシドを活性化した試檗をM止
剤として使用1yることにJ:り行なわれる。
The reaction to obtain the compound of formula (1) from the convex substance 11' of formula (13) is carried out using a dimethyl sulfoxide activated reagent as an M stopper.

斯かる81(薬どしでは、例えば]・リフルオロ61酸
無水物、オキザリールクロリド等の活性化剤とジメチル
スルホキシドとの爪を41げることができる。
Such 81 (in medicine, for example) can be combined with an activator such as fluoro61 acid anhydride or oxalyl chloride and dimethyl sulfoxide.

該ム(薬は、例えば1−ルエン、坦化エチ1ノン等の不
活性)d媒中で、l−記活性止剤とジメチルスルホキシ
ドとを処]!l!することにより鮎、ジルコされる。処
1M!温度及び処理時間どしては特に制御′41されな
い71’、通帛−78〜−50°C程厄、30分〜2時
間程石で処理ずればよい。斯くしてシラ製される1iI
taIiに式(13)の化合物を110えて、通常−7
8〜−50°C程度の温I衰に30分〜2時間稈1α反
応歇を維持−りるのがJ:い。式(13)の化合物に対
Jる」二記試共の使用品としては、1!口こ制+Ulさ
れず広々0囲内で適宜in II’s ′□!Jること
lr’できるが、通電式(13)の化合1シに対して上
記活性止剤及びジメチルスルホキシドの使用品か(れぞ
れ少くとも218モル聞(2度、好ましくは3〜51Δ
モルIii稈度とJるのがJ:い。次にこの反応flk
に1−リンチルアミン、トリエチルアミン等の1−リア
ルキルアミンを過剰■加えて、一般にO℃〜至温fJ 
ili:に反応tf&を30分〜2時間稈度保持゛す゛
ればJ:い。斯くして目的とする式(1)の化合物を1
i!!造できる。
The deactivating agent and dimethyl sulfoxide are treated in an inert medium such as 1-luene or platylated ethynone. l! By doing so, Ayu and Jirko are made. Place 1M! Temperature and treatment time are not particularly controlled, so the temperature should be about -78 to -50°C, and the treatment should be carried out with a stone for about 30 minutes to 2 hours. 1iI made in this way
Adding 110 of the compound of formula (13) to taIi, usually -7
It is good to maintain the culm 1α reaction for 30 minutes to 2 hours at a temperature of about 8 to -50°C. For the compound of formula (13), 1! In II's ′□ as appropriate within a spacious 0 area without oral control + Ul! However, it is possible to use the above-mentioned deactivator and dimethyl sulfoxide (at least 218 mol each (twice, preferably 3 to 51 Δ
The mole Iiii culm degree is J. Then this reaction flk
Add an excess of 1-realkylamine such as 1-lyntylamine or triethylamine to
J: If you react tf& to ili: and maintain the fertility for 30 minutes to 2 hours. In this way, the desired compound of formula (1) is
i! ! Can be built.

斯くして1すられる式(1)の化合物は、上記した各反
応行程の終了(22に1(j用の分Fi1手段により容
易にill蘭峙製できる。分■手段どしては例えば、)
d媒仙出法、カラムク[171〜グラフイー、蒸U等を
ψ゛げることができる。
The compound of the formula (1) thus obtained can be easily prepared by completing the above-mentioned reaction steps (22 to 1). )
It is possible to obtain d-media Sendeho, Kalamuku [171~Graphie, Steam U, etc.].

4に記式(1)の化合物を有効成分どして含有する抗カ
ビ剤は、医薬用、農園芸用、外用殺菌用等として用いら
れる。
The antifungal agent containing the compound of formula (1) as an active ingredient in 4 is used for medicine, agriculture, horticulture, external sterilization, etc.

医蘭用抗カビ剤どして用いるに当っては、通常一般的な
医薬製剤の形態で用いられる。製Allは通常使用され
る充填剤、増出剤、結合剤、付湿剤、崩壊剤、表面活性
剤、滑沢剤等の希釈剤あるいはpjt形剤を用いて調製
される。この医薬製剤としては各種の形態が)h療目的
に応じて選択でき、その代表的なものどして錠剤、乳剤
、散剤、液剤、乳剤、顆粒剤、カプセル剤、坐剤、注6
J剤(液剤等)笠が挙げられる。錠剤の形態に成形する
に際しては、担体としてこの分野で公知のものを広く使
用でき、例えば乳帖、白糖、川化す1〜リウム、ブドウ
紬、I7!水、デンプン、炭酸カルシウlい、カオリン
、結晶セルロース、ケイ百等の賦形剤、水、エタノール
、プロパツール、単シロップ、ブドウ紬欣、デンプン波
、ゼラチン溶液、カルボキシメチルセルロース、t′!
ラック、メチルセルロース、リン酸カリウム、ポリビニ
ルピロリドン等の枯含削、乾燥デンプン、アルギン顛す
1〜リウム、カンテン末、ラミナラン末、炭酸水水ブー
 1−リウlえ、炭酸カルシウム、ボリオギシエチレン
ソルビタン脂nh h!vエステル類、ラウリルLlt
 laす1−リウム、ステアリン故モノグリ[リド、デ
ンプン、乳ti!iVの崩壊剤、白糖、ステアリン、カ
カオバター、水素添加油等の161壊抑制剤、第A i
llllアンモニラ1基、ラウリル硫酸プ用・リウム等
の吸収(♀通則、グリt!リン、デンプン等の保)0剤
、デンプン、乳帖、力Aリン、ベンI・ナイト、コロイ
ド状ケイ酸$1の吸牡剤、積装タルク、ステアリン酸1
月、小つ斂末、ポリエチレングリコール等のHi沢剤等
がiA示できる。ざらに錠剤は必要に応じ1r1N常の
剤皮を施した錠剤、例えば帖衣錠、ゼラヂン袖包錠、胆
)U被疑、フィルムコーティング錠あるい1.に鎖錠、
多層錠とJることができる。乳剤の形Tdiに成形Jる
に際しては、11体として従来公知の°bのを広く使用
でき、例えばブドウ帖、乳結、デンプン、カカオnii
、硬化植物油、カオリン、タルク等の賦形剤、アラヒア
ゴム末、トラガント 結合剤、ラミナランカンテン等の崩壊剤等が例示できる
。坐剤の形fa+に成形するに際しては、担体として従
来公知のbのを広く使用でき、例えばポリ]ーヂレング
リコール、カカオ118、高級アルコール、高級アルコ
ールのエステル類、ゼラチン、半り成グリt2ライ1:
等を挙<yることツメできる。注ね4六りどじて調製さ
れる場合には、液剤は殺菌され、かつ白油ど等張である
のが好ましく、これら液剤及び乳剤の形態に成形するに
際しては、♀112剤としてこの分野において慣用され
ているものをずべて使用でき、例えば水、エチルアルコ
ール、プロピレングリコール、エトキシ化イソステアリ
ルアルコール ルljI等を挙げることができる。なJj、この場合等
張性の溶液をXlを騙1−!Jるに充分なωの農用、ブ
ドウ帖あるいはグリレリンを国典製剤中に白イ了せしめ
てもよく、また通常の溶解補助剤、Uu剤、無痛化剤等
を添加してもよい。更に必要に応じて七邑剤、保存剤、
香料、1虱味剤、1」味剤等や他のVAaIi品を医n
口11中に含有ヒしめてもにい。ベース(〜、クリーム
及びゲルの形態に成形するに際しては、希釈剤として例
えば白色ワl?リン、パラフィン、グリセリン、セルロ
ースI尋1本、ポリエチレングリコール、シリ:1ン、
ペン1〜ナイト等を使用できる。
When used as an antifungal agent for medicine or orchid, it is usually used in the form of a general pharmaceutical preparation. The product All is prepared using commonly used diluents such as fillers, extenders, binders, wetting agents, disintegrants, surfactants, lubricants, or pjt excipients. Various forms of this pharmaceutical preparation can be selected depending on the therapeutic purpose, and typical examples include tablets, emulsions, powders, liquids, emulsions, granules, capsules, suppositories, etc.
J agent (liquid agent etc.) Kasa is mentioned. When forming a tablet into a tablet, a wide variety of carriers known in this field can be used, such as lactose, white sugar, kawakasu 1-lium, grape pongee, and I7! Water, starch, calcium carbonate, kaolin, crystalline cellulose, excipients such as silicon, water, ethanol, propatool, simple syrup, grape pongee, starch wave, gelatin solution, carboxymethylcellulose, t'!
Lac, methylcellulose, potassium phosphate, polyvinylpyrrolidone, dried starch, alginium, agar powder, laminaran powder, carbonated water, calcium carbonate, ethylene sorbitan Fat nh h! v esters, lauryl Llt
la 1-rium, stearin late monogly [lido, starch, milk ti! iV disintegrants, white sugar, stearin, cocoa butter, hydrogenated oils, etc. 161 disintegration inhibitors, Part A i
llll ammonia 1 unit, absorption of lauryl sulfate, lithium, etc. (♀ general rule, maintenance of glyc t! phosphorus, starch, etc.) 0 agent, starch, milk clot, power A phosphorus, ben I night, colloidal silicic acid $ 1 stalactite, loaded talc, 1 stearic acid
IA can be shown by Hi-brightening agents such as lubrication, oxidation, polyethylene glycol, etc. Zaraani tablets may be coated with a 1r1N coating as required, such as a coated tablet, geladine cuff tablet, biliary tablet, film-coated tablet, or 1. locked,
It can be called a multilayer tablet. When molding into the emulsion form Tdi, a wide range of conventionally known substances can be used, such as grapes, milk, starch, cacao, etc.
Examples include excipients such as , hydrogenated vegetable oil, kaolin, and talc, disintegrants such as arachia gum powder, tragacanth binder, and laminalan agar. When forming the suppository form fa+, a wide range of conventionally known carriers can be used, such as poly]-dylene glycol, cacao 118, higher alcohols, esters of higher alcohols, gelatin, and semi-containing glycol t2. Rai 1:
I can think of things like. Note 4: When prepared in bulk, the solution is preferably sterilized and isotonic with white oil. All commonly used ones can be used, such as water, ethyl alcohol, propylene glycol, ethoxylated isostearyl alcohol, and the like. Jj, in this case the isotonic solution is Xl 1-! A sufficient amount of omega for agricultural purposes, grapes, or glycerin may be added to the national prescription preparation, and conventional solubilizing agents, uu agents, soothing agents, etc. may be added. Furthermore, if necessary, Shichibu agents, preservatives,
Flavorings, flavoring agents, flavoring agents, etc. and other VAaIi products should not be used medically.
It's hard to keep it in your mouth. Base (~, when forming into cream and gel form, use diluents such as white wax, paraffin, glycerin, 1 thick of cellulose, polyethylene glycol, 1 thick of silicone,
Pen 1 to Knight etc. can be used.

本発明の抗力じ剤中に含aされるべき式(1)の化合物
のωとしては、特に限定されり°広範囲に適宜)■択さ
れるが、通帛抗ノJビ剤中1〜701%どするの11〜
J:い。
The ω of the compound of formula (1) to be contained in the anti-strain agent of the present invention is not particularly limited and may be selected from a wide range (as appropriate); % What to do 11~
J: Yes.

上記抗カビ剤の投局方法は特に制御42 11なく、各
(!I! !EJ剤形態、思召の年ム11、性別での曲
の条件、患者の程庶等に応じた方法で1仕与される。例
えば錠剤、乳剤、液剤、乳剤、1131粒剤及びカブレ
ル剤の場合にロ経ロ投与される。また11:r+J剤の
場合には単独であるいはブドウね、アミノ酸等の通常の
補液ど)捏合して靜let内投与され、更には必要に応
じて単独で116内内、皮肉、皮下もしり11和睦内投
与される。坐剤の場合には直11」内投与され、また軟
H剤の場合には線面される。
The method of administering the antifungal agent mentioned above is not particularly controlled; it can be administered in one manner according to each (!I!! EJ formulation, desired age, gender, condition of the song, and the patient's level of control). For example, in the case of tablets, emulsions, solutions, emulsions, 1131 grains, and Cabrel's tablets, it is administered by oral route.In the case of 11:r+J tablets, it is administered alone or with regular replenishers such as grapevine, amino acids, etc. etc.) Knead and administer intravenously, and if necessary, administer alone intravenously, intradermally, or subcutaneously. In the case of suppositories, it is administered straight into the mouth, and in the case of soft tablets, it is administered in a line.

上記国典tJ剤の投与旦は用法、患者の年齢、性別その
他の条件、疾患の程度等にJ:り適宜選択されるlr’
、通常有り」成分である式(1)の化合物のjAlfi
 I FI当’)(411i 1 k(1”iす約0.
 2〜1 00nIOトりるの7)\よい。
The administration date of the above-mentioned National Standards tJ drug is selected as appropriate depending on the usage, age, sex and other conditions of the patient, degree of disease, etc.
jAlfi of the compound of formula (1), which is usually a "component"
I FI t') (411i 1 k(1"i about 0.
2-100nIO Toriruno 7)\Good.

また展回芸用抗カビ剤として用いるに当っては、式(1
)の化合物を従来この分野で公知の担体と混名してこれ
を散布すればにい。
In addition, when used as an antifungal agent for exhibitions, the formula (1
) can be mixed with a carrier known in this field and sprayed.

以下に抗カビ試験結果、式(1)の化合物の製造例及び
uA1例を挙げる。
The antifungal test results, a manufacturing example of the compound of formula (1), and an example of uA are listed below.

抗カビ試鋏 式(1)の化合物についての1!11々の菌に対する抗
カビ作用を調べるため、寒天希釈平板法により最少増殖
111止m度を求めた[ CHEMOTI−IEflAPY.22.1 1 26
〜1128(1974)参照]。li+られる結栗を下
肥第1表に示″!J−。
Antifungal assay In order to investigate the antifungal effect of the compound of formula (1) on 1!11 bacteria, the minimum growth rate of 111 was determined by the agar dilution plate method [CHEMOTI-IEflAPY. 22.1 1 26
1128 (1974)]. The chestnuts that can be treated with li+ are shown in Table 1.''!J-.

第1表 供  試  iMl           最少j台殖
阻止淵1な(l」−ど1) S accal’ollyces   OOI’f3V
ISlae     O 、’ 7 8Scblzos
accl+arolyces  p01111N3  
   Q,3(1)+1an!ienLIIa  an
ou+ala          1 、  5 6C
anditla  uLllia          
   1 、  5 6Scleroロ+11a  l
lllor口ana     3.13Mucor  
mucado             2 5R b
izopus  chlnensis      l 
2 、5Asperc+illus  nloer  
       1 2 、  5Peniailliu
m   crustosum            
6.   25製造例 (1) 式(3)の化合物の製造 シアン化カリ″1.30及び塩化アンモン8 0 0 
111CIを水101どジメチル小ルムアミド(Dfv
lF)601のULIIljにmiVする。lJi 1
fJ液に室温(18°C)で式(2)の化合物20を少
憬のDMFに171解して)^下J°る。同温陵で50
.!J間1d拌後水1201111加え、次いでエーテ
ル抽出J−る。飽和食塩水で洗浄し、rlI!i義すト
リウムを用いて乾燥した後、減圧濃縮する。
Table 1 Sample iMl Minimum j-inhibition depth 1 (l'' - 1) Saccal'ollyces OOI'f3V
ISlae O,' 7 8Scblzos
accl+arolyces p01111N3
Q, 3(1)+1an! ienLIIa an
ou+ala 1, 5 6C
anditla uLllia
1, 5 6Sclero+11a l
lllor mouth ana 3.13 Mucor
mucado 2 5R b
Izopus chlnensis l
2, 5Aperc+illus nlower
1 2, 5 Peniailliu
mcrustosum
6. 25 Production Example (1) Production of compound of formula (3) Potassium cyanide 1.30 and ammonium chloride 800
111CI to water 101 dimethyl small lumamide (Dfv
IF) miV to ULIIlj of 601. lJi 1
Compound 20 of formula (2) was dissolved in a small amount of DMF at room temperature (18°C) in fJ solution. 50 at Doon Mausoleum
.. ! After stirring for 1 day, add 1,201,111 liters of water, and then extract with ether. Wash with saturated saline and rlI! After drying with thorium, concentrate under reduced pressure.

残漬を1ti1層クロマI−グラフィー(展開溶媒エー
テル−f\キザン(v/v)=1:1)で精製して式(
3)の化合物2.20を1!Iる。得られる化合物のN
MRスペクトル図(100Mt−1z 、CCI 、、
TMS)を第1図に示す。
The residue was purified by 1ti1 layer chroma I-graphy (developing solvent ether-f\kizan (v/v) = 1:1) to obtain the formula (
3) compound 2.20 to 1! I. N of the resulting compound
MR spectrum diagram (100Mt-1z, CCI,...
TMS) is shown in FIG.

(2) 式(4)の化合物の製造 上記でlidられる式(3)の化合物2501u(1(
1,1ミリモル)を81のエタノールに溶解する。10
96パラジウムー炭シぞ101Oを加えて、氷水気流中
室)門で51′1.¥間1itJv!する。セライト廁
過し、濾液を減圧濃縮して式(4)の化合物254 b
aaを(!Iる。得られる化合物のN M Rスペクト
ル図(100Ml−1z。
(2) Production of compound of formula (4) Compound 2501u (1(
1.1 mmol) is dissolved in 81 ml of ethanol. 10
Add 96 palladium on charcoal and 101 O, and heat to 51'1. ¥1itJv! do. The filtrate was concentrated under reduced pressure to obtain compound 254b of formula (4).
NMR spectrum of the resulting compound (100 Ml-1z.

ccl 、、TMS)を第2図に承り。ccl,,TMS) as shown in Figure 2.

(3) 式(5)の化合物の製造 一1二配(2)で得られる式(4)の化合物23711
10(1,01ミリモル)、エチ1ノングリコール69
■0及び触kit tilのll−1〜ルエンスル小ン
酸をベンピン6 m l中で3.5時間共IN脱水を行
なう。水冷下炭酸水水プ用−リウム);)末を加え10
分1ii11+i拌する。1−−チル50m1で抽出し
、飽和m凸ホ、飽(11良JM水で各2回洗浄、硫酸す
1−リウムで92;拳(す、b、A圧濃紬して式(5)
の化合物303+ngを(47る。(1られる化合物の
NMR−スペクトル図(60M IIZCCI 4.T
MS)をム1′43図に示J0(4) 式(6)の(1
1合物の製造 上記で(nられる式(5)の11−合物303 mgを
共)JB 1112水し、11((ホへキリ゛ン25a
IIに)d解1′る。へ4:ザン)d液を一70°Cに
市川し、ジイソブチルアルミニウムヒドリL’0.60
2m1を加え同温度で30分1i11−t! 1°る。
(3) Preparation of compound of formula (5) Compound 23711 of formula (4) obtained in step (2)
10 (1.01 mmol), ethyl non-glycol 69
(1) Dehydration of 0 and 11-1 to luenesulfonic acid was carried out in 6 ml of bempine for 3.5 hours. Add 10% carbonated water under water cooling and add 10%
Stir for 1ii11+i minutes. Extract with 50 ml of 1-chill, wash twice each with saturated JM water, 92% with 1-lium sulfate;
NMR-spectrum diagram of the compound (60M IIZCCI 4.T
MS) is shown in Figure 1'43 J0 (4) (1 of equation (6)
Preparation of Compound 1 In the above process, 303 mg of 11-compound of formula (5) was diluted with JB 1112 water,
II) d solution 1'. Step 4: Heat the d solution to -70°C and diisobutylaluminum liquid L'0.60.
Add 2ml and leave at the same temperature for 30 minutes! 1 degree.

更に一45〜30℃T’ 3 II!fliu IR拌
(長、飽411川化アンモニウム101を加えて20分
1til IJl拌する。596のrl 鹸’3 、5
 +++lを加えエーテル抽出゛する。飽和m白水、飽
和食塩水で各1回洗浄し、威圧目線J”る。残ihを薄
層クロマ1〜グラフイー(展開tfJ媒エーテル−ヘキ
サン(V /V ) −1:1)で分離して式(6)の
化合物 2.851110を得る。得られる化合物のNMRスペ
クトル図(100M1iz 、CCI 、。
Furthermore -45~30℃T'3 II! fliu IR stirring (long, saturated 411 Add ammonium 101 and stir for 20 minutes 1 til IJl. 596 rl Ken'3, 5
Add +++ l and extract with ether. Wash once each with saturated white water and saturated saline, and remove the residue using thin layer chroma 1~graphie (developing medium ether-hexane (V/V) -1:1). Compound 2.851110 of formula (6) is obtained. NMR spectrum of the obtained compound (100M1iz, CCI,.

T M S )を第4図に示す。TM S) is shown in FIG.

(5) 式(7)の化合物の1;告 」−記で(けられる式(6)の化合物1.0(1を50
 % M1酸20m1に溶解し、アルゴン気)h中75
〜80′Gで25分間加熱する。水冷下iI2凸わ)末
を加え、エーテル抽出′す°る。飽和m曲水で5回、飽
和食塩水で1回)丸浄し、次に硫酸す1−リウムで乾燥
後舐圧饋縮する。残漬を1W層クロマ1〜グラフィー(
111間溶媒エーテル−ヘキサン(V/V )=1 :
  1)で1!製して式(7)の化合物1.56!]を
(iIる。
(5) The compound of the formula (6), which is 1.0 of the compound of the formula (7);
% M1 acid dissolved in 20 ml under argon atmosphere) 75 h
Heat at ~80'G for 25 minutes. Add the powder to the mixture under water cooling and extract with ether. Rinse thoroughly (5 times with saturated water and once with saturated saline), then dry with 1-lium sulfate and compress. 1W layer chroma 1~graph (
111 solvent ether-hexane (V/V) = 1:
1) and 1! The compound of formula (7) is 1.56! ] to (iIru.

(6) 式(8)の化合物(R’−1t2−メチル)の
製造 上記で(シIられる式(7)の化6物10及び式(15
)の化合物(RI =11”−メチル)3.90を無水
ベンピン201に)dシdし、次いでアルゴン気流中2
0時間’rW流−リ“る。鍼圧濃創6後、カラムクロマ
ト分1J1(ベキ1J−ンーエーテル(V/V)=3:
2)Ltて式(8)の化合物(Ill−112−メチル
) E396h+oti−1する。ltIられる化合物
のN MRスペクトル図(100tvlHz 、 CC
I 4 、 TMS )を第5図に示ず。
(6) Production of compound (R'-1t2-methyl) of formula (8) Compound 10 of formula (7) and formula (15
3.90 of the compound (RI = 11”-methyl) of ) was dissolved in anhydrous bempine 201), then 2 d in a stream of argon.
0 hour'rW flow - Re'. After 6 acupuncture incisions, column chromatography 1J1 (power 1J - ether (V/V) = 3:
2) Compound of formula (8) (Ill-112-methyl) E396h+oti-1. NMR spectrum of the compound subjected to ltI (100tvlHz, CC
I 4 , TMS) are not shown in FIG.

(7) 式(0)の化合’IIJ(R’=11”メチル
)の製造 上記で1iIられる式(8)の化合物(R1−R2−メ
チル)806mg、エチlノングリコール108 mO
及びp−1〜ルエンスルホン椴0011Ioをベンt!
ン30 b+ 1中で3.5時間jl: y11脱水を
行なう。氷冷下IJ! imホ索す]・リウムわ)末を
加え10分聞lid拌する。エーテル501で抽出し、
飽和用曲水、飽和良j温水で各2回洗浄、Ut醸す1−
リウムで乾怨1長、減圧濃1iii シて式(9)の化
合物(R’ =i12−メチル)を得る。lidられる
化合物のN M r<スペクトル図(100MHz 、
CCI 、、TMS)を第一6図に示V0 (8) 式〈10)の化合物の製造 上記で11られる式(9)の化合物(R1−R2,メチ
ル)に無水エーテル100+ulを加え、次いでIjX
拌下に水素化アルミニウムリチウム7118Ill!1
を加えて変温で311′1間20分反応さ「る。次にエ
ーテル抽出し、抽出液を鑓eIit L/、式(10)
の化合物を得る。該化合物をそのまま次の反応に使用す
る。
(7) Production of compound 'IIJ of formula (0) (R' = 11'' methyl) 806 mg of the compound (R1-R2-methyl) of formula (8) 1iI above, 108 mO of ethyl non-glycol
And p-1 ~ Ruensulfon 椴0011Io bent t!
Dehydration is carried out for 3.5 hours in a tank 30b+1. IJ under ice cold! Add the powder and stir for 10 minutes. Extract with ether 501,
Wash twice each with saturated water and saturated warm water, then brew 1-
The compound of formula (9) (R' = i12-methyl) is obtained by drying with sodium hydroxide and concentrating under reduced pressure. N M r<spectrum diagram of the compound to be lidded (100 MHz,
CCI,, TMS) is shown in FIG.
Lithium aluminum hydride 7118Ill under stirring! 1
was added and reacted for 20 minutes at a variable temperature for 311'1.Next, it was extracted with ether, and the extract was poured into a filtrate using the formula (10).
The compound is obtained. The compound is used as is in the next reaction.

(9) 式(’+ 1 )ぐ化合物(R3−アレチル)
め1造 」二記で得られる式(10)の化8物、ピリジン10b
+I及び無水酢l11121をプjζ冷下−夜故U後、
減圧下にJIJ媒を留去して、次いで水を加えてエーテ
ル抽出−ツる。?lS川酸用洗浄、水洗+′fi後エー
テル届を淵1+il C1て、ア(?デル化され1.:
化合物を1>)る。
(9) Compound of formula ('+ 1 ) (R3-aretyl)
Compound 8 of formula (10) obtained by Me1zo'2, pyridine 10b
+I and anhydrous vinegar l11121Pjζ After cooling down at night,
The JIJ medium was distilled off under reduced pressure, and then water was added and extracted with ether. ? After washing with lS river acid, washing with water + 'fi, the ether notification is applied to the deep 1+il C1, and it is converted into a (?del) 1.:
Compound 1>).

次いで該11−合物を50%酢1d1(3r++1に)
i)F MVし、アルゴン気流中75〜80°Gで25
分加熱する。氷°冷下117曽粉末を加λ、エーテル抽
出する。飽和臆會水で5回、飽和食塩水で′1劇洗浄し
、次にしI[l1ilすトリウムで乾燥もJilλ几−
1+1f−Iiる。残漬を)1シ1ΔりI]7トグラフ
イー(痕1jil iB媒エーテルーヘキリン(■、′
シフー・1:1)でiN観し0式(11)の1[二合物
(R3−ア(ごチノ」暑8 !’s 2 n+gを得る
。得られる化合物のN M lでスペクトル図(100
Ml−1z 。
Then, the 11-compound was added to 1d1 of 50% vinegar (to 3r++1).
i) F MV, 25 at 75-80°G in argon flow
Heat for a minute. Under ice-cooling, the 117-so powder was added with λ and extracted with ether. Wash thoroughly with saturated water 5 times and saturated saline, then dry with thorium.
1+1f-Iiru. (remaining) 1 1 Δ ri I] 7 tographie (1 jil iB medium ether hekylin (■, ′
Obtain the compound (R3-a(gochino) 8!'s 2n+g) of formula (11) by observing the iN with a Sifu 1:1).The spectrum diagram ( 100
Ml-1z.

CCI 、、王MS )を多1′17図に示−リ゛。CCI, Wang MS) is shown in Figure 1'17.

(10) 式(12)の化合4>J (It ” =’
71= チRi )の叡r’r与 氷結11−すトリウム22 b+(J及Uジメチルスル
ホキシi’ (1)MSO) 1 、zl山l’27j
しlf’z気流中70〜80 ’Cに−C30分加熱す
゛る。該Iah髪を全1品(二戻し、′ツメ1−1ニジ
■タン6n11を加える。次いで該11y欣を−10〜
−−2(’) ’Cに冷ノDし、トリメチルスル ’J 4 nIQ’D D MSo 1 、 4 1+
lIにfk ’k 3分Ni’ L −C加える。5分
間lid拝した後、1−記で(tIられる式(11)の
11コ8・′1カ(Rターアレチル)144moのジメ
トギシエタン2.5b+l洛液を30秒で加える。同)
8度で10分撹拌後、水浴を除去して50分間1β拌す
る。水冷下水301を加え、エーテル抽出する。飽和食
塩水で3回洗)−一シ、硫酸すトリウムで乾燥した後減
圧ぬ縮J′る。残漬をピリジン31に溶解し、無水へY
酸0.7mlを加え、反応)々を苗)Uで6時間撹拌後
、濃縮、次いでエーテル抽出Jる。エーテル層を希塩1
1!!、水で洗浄した後自jl& L,、カラムク[1
71・分離(ヘキリ゛ンー工ーテル(v/v)−4:1
)して式(12)の化合物(R3−アセチル) 4 1
 11IOを1#Iる。
(10) Compound 4>J (It ” =' of formula (12)
71= ri r'r freezing of 11-storium 22 b+ (J and U dimethyl sulfoxy i' (1) MSO) 1, zl mountain l'27j
Heat to 70-80'C in a stream of -C for 30 minutes. Add all 1 product of the Iah hair (restored twice, 'Tsume 1-1 Niji Tan 6n11. Then add the 11y hair to -10 ~
--2(')' Cold D to C, trimethylsul'J 4 nIQ'D D MSo 1, 4 1+
Add fk 'k 3 min Ni' L -C to lI. After stirring for 5 minutes, add 144 mo of dimethoxyethane 2.5 b + l solution of formula (11) (tI) in 30 seconds.
After stirring for 10 minutes at 8 degrees, remove the water bath and stir for 1β for 50 minutes. Add water-cooled sewage 301 and extract with ether. Washed three times with saturated saline solution) - dried over sodium sulfate and concentrated under reduced pressure. Dissolve the residue in pyridine 31 and transfer to anhydrous Y
Add 0.7 ml of acid, stir the reaction mixture for 6 hours, concentrate, and then extract with ether. Add 1 dilute salt to the ether layer
1! ! , After washing with water, columnar [1
71・Separation (hekilyne-ether (v/v)-4:1
) and the compound of formula (12) (R3-acetyl) 4 1
11IO to 1#I.

liJられる化合物のN M Rスベク1−ルUA(1
 00MI−1.z 、CCI t 、TMS)を第8
図に示づ。
N M R subvec 1 - UA (1
00MI-1. z , CCI t , TMS) as the eighth
As shown in the figure.

(11) 式(13)の化合物の製造 上記で4iJられる式(12)の化合物(113−ア[
デル) 4 I nlftを炭N 7J IJ 6 0
 mg、1ノール4.5+nl及び水611+1に加え
、30°Cにて3詩間It拌する。次に希馬酸で中和後
エーテル抽出J゛る。エーテルItsを水洗し、)a媒
を留去して式(13)の化合物を11 、i5。該化合
物は、モレ4:ユラシーブで92爆後次の6々化処理を
行なう。
(11) Production of compound of formula (13) Compound (113-a[
Dell) 4 I nlft Charcoal N 7J IJ 6 0
mg, 4.5+nl of 1 nor and 611+1 of water and stirred for 3 minutes at 30°C. Next, it is neutralized with dilute maric acid and extracted with ether. The ether Its was washed with water, and the solvent a) was distilled off to obtain the compound of formula (13). The compound was subjected to the following hexagonalization treatment after 92 bombardments with MOLE 4: URASIBE.

(12) 式(1)の化名物の製造 DMSO3 1 、 4+aliJfJM化メフl//
(’1.1m l IC 、iu解し、−50°0に冷
711−!I’る。該runに1− ’) フル:41
−17a(7J<hVh16 3 、 5moe 1 
0分装して加λる。100il JP蜆、」ニ配で得ら
れる式(13)の化合物の塩化メチ1ノン1mlidR
シを10分間要して加える。同温度で30分1に拌後、
O 、  ’I 5 mlσ) l−リ2エチルアミン
を3分で加え、次いで室温にて40分1iX拌づる。水
冷上飽和mv1水を加えてエーテル抽出゛りる。
(12) Production of the chemical compound of formula (1) DMSO3 1 , 4 + aliJfJM mef l//
('1.1ml IC, iu dissolved, cooled to -50°0 711-!I'. 1-' for the run) Full: 41
-17a (7J<hVh16 3 , 5moe 1
Divide into 0 and add. 100il JP Mu, 1 mlidR of methionone chloride of the compound of formula (13) obtained by
Add the shiitake for 10 minutes. After stirring at the same temperature for 30 minutes,
O,'I5mlσ) l-ly2ethylamine was added over 3 minutes and then stirred 1iX for 40 minutes at room temperature. Add saturated mv1 water to the water-cooled mixture and perform ether extraction.

飽和食塩水で2回)ん81ノ、硫酸すトリウ!いで乾燥
し、b.1圧)ム柿1jン、:i鎗1.、jり「】7ト
グラフイー(展を用itJ’Aヘキリ゛ンーエーテノI
J(V/V)=11)で1h製して式(1)化合物14
m□を得る。得られる化合物のN M Rスペクトル図
(1 00Mtlz 、 GDCI g 、 TMS)
を第9図に承り。
(twice with saturated saline) 81, sulfuric acid! b. 1 pressure) Mu persimmon 1jn, :i spear 1. ,J'A Hekirien-Etheno I
J (V/V)=11) for 1 h to obtain compound 14 of formula (1).
Obtain m□. NMR spectrum diagram of the obtained compound (100Mtlz, GDCIg, TMS)
Please refer to Figure 9.

製剤例 1 式(1)の化合物          100gアビシ
ェル(商標名、旭化成(14)14)    40(1
コンスターチ             300゜ステ
アリン酸マグネシウム        207O−51
0゜ (商品名、信越化学工業((1)装、 ヒト[1キシプロピルメチルセルロース)ポリエチレン
グリコール−600030ヒマシ浦         
       400メタノール          
    4O。
Formulation example 1 Compound of formula (1) 100g Abishel (trade name, Asahi Kasei (14) 14) 40 (1
Cornstarch 300° Magnesium Stearate 207O-51
0゜ (Product name, Shin-Etsu Chemical Co., Ltd. (1), Human [1-xypropyl methylcellulose) polyethylene glycol-600030 Himashiura
400 methanol
4O.

式(1)の化合物、アビシェル、]ンスターチ及びステ
アリン酸マグネシウムを取り111!合rJI IFr
 Uj帖衣R10111blのキネで打錠する。lIら
れた錠剤をTO−5、ポリエチレングリコール−600
0、ヒマシ油及びメタノールからなるフーrルムコーテ
ーtング剤で被1dを行ない上記、111 Jのフィル
ムコーチ、fング錠を1造する。
Take the compound of formula (1), Abishel, starch and magnesium stearate and 111! Combined rJI IFr
Compress the tablets with a Uj Choi R10111bl machine. TO-5, polyethylene glycol-600
A film coated tablet of the above 111 J was prepared by coating with a film coating agent consisting of castor oil and methanol.

製剤例 2 式(1)の化8物            21Jin
ラノリン               5゜ザラシミ
ツロウ             5゜白色ワセリン 
            88゜υラシミツロウを加I
LA 1ノで)1シ状とし、次いで式(1)の化名物、
精製ラノリンノ及び白色ワeリンを加え液状となるまで
加温(h、固化し始めるまで撹拌して、上記4rl成の
軟口剤を1シIる。
Formulation Example 2 Compound 8 of formula (1) 21Jin
Lanolin 5° coarse beeswax 5° white petrolatum
Add 88゜υ lassi beeswax
(LA 1)), then the compound of formula (1),
Add purified lanolin and white walnut and heat until it becomes liquid (h) Stir until it begins to solidify, then add 1 cup of the above 4ml composition soft mouth preparation.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は式(3,)の化合物のN NII Rスペクト
ル図である。第2図は式(4)の化合物のN M r<
スベク1−ル図である。狛3図は式(5)の化合物のN
 M Rスベク1〜ル図である。狛4図は式(6)の化
合物のN M Rスベク1−ル図である。第5図は式(
8)の化8・物(RI =r12−メチル)のN lv
l Rスペクトル図である。h′16図はコt:(9)
の化合物(R1−112−メチル)のNMRスペクトル
図である。第7図は式(1′l )の化合物(R3−ア
セチル)のNN・IRスベクトルロである。多118図
は式(12)の化合物(R3−アレチル)のN M R
スペクトル図である。第9図は式(1)の化合物のN 
M RスペクI・ル図である。 (以  上  ) 代理人 弁理°1− 三 1.′!  英 二 。
FIG. 1 is a N NII R spectrum diagram of the compound of formula (3,). Figure 2 shows that N M r< of the compound of formula (4)
It is a block diagram. Koma 3 diagram shows N of the compound of formula (5)
FIG. 1 is a diagram of MRS vectors. Figure 4 is an NMR spectrum diagram of the compound of formula (6). Figure 5 shows the formula (
8) N lv of chemical compound 8 (RI = r12-methyl)
It is an lR spectrum diagram. Figure h'16 is here: (9)
It is an NMR spectrum diagram of the compound (R1-112-methyl). FIG. 7 shows the NN/IR spectrum of the compound (R3-acetyl) of formula (1'l). Figure 118 shows the NMR of the compound (R3-aretyl) of formula (12).
It is a spectrum diagram. Figure 9 shows the N of the compound of formula (1).
It is an MR spectrum diagram. (Above) Attorney °1-3 1. ′! Eiji.

Claims (1)

【特許請求の範囲】[Claims] (1)式 で示される(E)−13β、17.−:rボキシラブド
−12−−V、シー15.16−ジアールを有効成分ど
して含有することを特数とJ゛る族カビ剤。
(E)-13β, 17. -: A group J fungicide characterized by containing r-boxyrabdo-12--V and c-15.16-dial as active ingredients.
JP15758282A 1982-09-09 1982-09-09 Antifungal agent Granted JPS5946202A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15758282A JPS5946202A (en) 1982-09-09 1982-09-09 Antifungal agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15758282A JPS5946202A (en) 1982-09-09 1982-09-09 Antifungal agent

Publications (2)

Publication Number Publication Date
JPS5946202A true JPS5946202A (en) 1984-03-15
JPH0330565B2 JPH0330565B2 (en) 1991-04-30

Family

ID=15652843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15758282A Granted JPS5946202A (en) 1982-09-09 1982-09-09 Antifungal agent

Country Status (1)

Country Link
JP (1) JPS5946202A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010919A1 (en) 1988-05-02 1989-11-16 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010919A1 (en) 1988-05-02 1989-11-16 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Also Published As

Publication number Publication date
JPH0330565B2 (en) 1991-04-30

Similar Documents

Publication Publication Date Title
EP1845978B1 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
JPH01272574A (en) Hypoglycemic thiazolidine dione derivative
TW568902B (en) New vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
US4436934A (en) Bicyclic prostaglandin analogs and method of synthesis
Truce et al. Stereoselective sulfene-tropone cycloadditions and stereospecific thermolysis of resulting adducts
JPS5946202A (en) Antifungal agent
US4351949A (en) Bicyclic prostaglandin analogs and method of synthesis
DE2705613A1 (en) BICYCLOALKYL DERIVATIVES OF PROSTAGLANDINES
JPS61103850A (en) 3-(indan-5-yloxy(or thio))cyclopentanecarboxylic acid derivative, its production, and remedy containing same as active ingredient
US20190194107A1 (en) Method of synthesis
US8410314B1 (en) Method of synthesis
CN113004268B (en) Thiazole compound for inhibiting tumor cell growth and application thereof
JP3839518B2 (en) Antifungal
JPS62482A (en) Prostacyclines
Kwant Synthesis of deuterated pentacenes
JPS63284169A (en) Novel derivative of forskoline, manufacture and intermediate, use as medicine and medicinal composition
BE898169A (en) Amide derivatives of 13,14-didehydro-cycloalkyl-prostaglandins.
CN105473547B (en) The new compound of agomelatine and sulfonic acid, preparation method and the pharmaceutical composition comprising it
JP2621122B2 (en) 2-Substituted-2-cyclopentenones and anticancer and osteogenesis promoters containing the same as an active ingredient
JPS6396155A (en) Novel terpene compound and anti-inflammatory agent containing said compound
US1169316A (en) Camphor compounds.
JPH06211728A (en) 5-methylene-2-cyclopentenones and carcinostatic agent and bone formation promoter containing the same
Burlaka et al. Radical addition reaction of alcohols to 1-(4-nitrophenyl)-5H-pyrrolin-2-one
JPS6153261A (en) Branched-chain sulfur-containing compound
JPS6050771B2 (en) Method for producing methyl-norbornene derivative